Does tuberculosis increase HIV load?

被引:58
作者
Day, JH
Grant, AD
Fielding, KL
Morris, L
Moloi, V
Charalambous, S
Puren, AJ
Chaisson, RE
De Cock, KM
Hayes, RJ
Churchyard, GJ
机构
[1] Univ London London Sch Hyg & Trop Med, Clin Res Unit, London WC1E 7HT, England
[2] Natl Inst Communicable Dis, Johannesburg, South Africa
关键词
D O I
10.1086/424851
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. The effect that tuberculosis ( TB) has on human immunodeficiency virus (HIV) disease progression is not clearly understood. Methods. In an observational cohort study of HIV-infected adults in South Africa, baseline and final HIV load were compared between individuals who experienced an episode of TB (n = 30) during follow- up and control subjects (n = 56) matched by baseline CD4 cell count and follow- up time; linear regression modeling was used to control for confounding. Results. Mean HIV load was higher in the TB group than in the non-TB control group for both baseline (4.73 vs. 4.24 log(10) copies/mL; P = .003) and final values (5.02 vs. 4.34 log(10) copies/mL; P < .001). After adjustment for baseline HIV load and World Health Organization HIV stage, the difference in final HIV load was 0.24 log 10 copies/mL (95% confidence interval, - 0.01 to 0.50 log(10) copies/mL; P = .06). Conclusions. Poor prognosis for HIV-infected individuals after TB may be due to preexisting high HIV load rather than to the TB event itself. An episode of TB was associated with a small adjusted increase in HIV load at the end of the study - an increase that would not be regarded as clinically significant in an individual but could have some effect on HIV disease progression or HIV transmission at the population level. Prevention of TB is important for the reduction of HIV-related morbidity and mortality; however, antiretroviral therapy is required to have a major effect on survival in individuals with HIV disease.
引用
收藏
页码:1677 / 1684
页数:8
相关论文
共 50 条
[41]   Prognostic indicators for AIDS and infectious disease death in HIV-infected injection drug users -: Plasma viral load and CD4+ cell count [J].
Vlahov, D ;
Graham, N ;
Hoover, D ;
Flynn, C ;
Bartlett, JG ;
Margolick, JB ;
Lyles, CM ;
Nelson, KE ;
Smith, D ;
Holmberg, S ;
Farzadegan, H .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (01) :35-40
[42]   ACCELERATED COURSE OF HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION AFTER TUBERCULOSIS [J].
WHALEN, C ;
HORSBURGH, CR ;
HOM, D ;
LAHART, C ;
SIMBERKOFF, M ;
ELLNER, J .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1995, 151 (01) :129-135
[43]   Impact of pulmonary tuberculosis on survival of HIV-infected adults: a prospective epidemiologic study in Uganda [J].
Whalen, CC ;
Nsubuga, P ;
Okwera, A ;
Johnson, JL ;
Hom, DL ;
Michael, NL ;
Mugerwa, RD ;
Ellner, JJ .
AIDS, 2000, 14 (09) :1219-1228
[44]  
*WHO, 2002, 104 WHO
[45]  
*WHO, 2001, WHOCDSTB20012872001
[46]  
*WHO, 1990, WKLY EPIDEMIOL REC, V65, P221
[47]  
WILKINSON D, 2002, COCHRANE DATABASE SY
[48]  
Wolday H, 2003, INT J TUBERC LUNG D, V7, P110
[49]  
Wood R, 2000, J ACQ IMMUN DEF SYND, V23, P75
[50]   MYCOBACTERIUM-TUBERCULOSIS ENHANCES HUMAN IMMUNODEFICIENCY VIRUS-1 REPLICATION BY TRANSCRIPTIONAL ACTIVATION AT THE LONG TERMINAL REPEAT [J].
ZHANG, YH ;
NAKATA, K ;
WEIDEN, M ;
ROM, WN .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (05) :2324-2331